Guardant Health hit with $83.4M patent infringement verdict; will appeal

Guardant Health, Inc.

Jury found willful infringement of two patents; awarded $83.4M in damages (6% royalty on past sales).
Plaintiffs may seek up to treble damages (≈$250M) based on the willfulness finding.
Guardant strongly disagrees, plans post-trial motions and appeal to Federal Circuit.
Company says verdict unlikely to materially impact business but may require future royalty payments if upheld.
Case: TwinStrand Biosciences, Inc. and Univ. of Washington v. Guardant Health, C.A. No. 21-1126-GBW-SRF.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.